| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |